DrugPatentWatch Database Preview

Crisaborole - Generic Drug Details

« Back to Dashboard

What are the generic sources for crisaborole and what is the scope of crisaborole freedom to operate?

Crisaborole is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Crisaborole has one hundred and eleven patent family members in twenty-two countries.

One supplier is listed for this compound.

Summary for crisaborole

International Patents:	111
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	49
Clinical Trials:	4
Patent Applications:	40
Drug Prices:	see low prices
DailyMed Link:	crisaborole at DailyMed

Pharmacology for crisaborole

Drug Class	Phosphodiesterase 4 Inhibitor
Mechanism of Action	Phosphodiesterase 4 Inhibitors

Synonyms for crisaborole

1073669-75-6

1187189-21-4

4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE

4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile

4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile

4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile

4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile

4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile

4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile

5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole

5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole

5098AC

906673-24-3

ABP001114

AK102641

AKOS016005425

AN 2728

AN-2728

AN2728

ANW-65536

API0013781

AX8234180

BC245091

BDBM50277665

Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-

Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-

C14H10BNO3

CHEBI:134677

CHEMBL484785

compound 5b [PMID: 19303290]

Crisaborole (USAN/INN)

Crisaborole [USAN:INN]

Crisaborole topical ointment 2%

Crisaborole, >=98% (HPLC)

Crisaborole(AN-2728)

CS-1057

CTK8C0958

D0SM0W

D10873

DB-078771

DB05219

DTXSID10238231

Eucrisa

Eucrisa (TN)

EX-A1087

FT-0767999

GTPL9151

HE053309

HE268247

HY-10978

KB-40872

KS-0000063U

MFCD17169940

MolPort-023-332-548

NCGC00345792-01

Q2R47HGR7P

SCHEMBL595261

ST24042710

TC-154281

UNII-Q2R47HGR7P

USZAGAREISWJDP-UHFFFAOYSA-N

W-5676

ZINC169748244

US Patents and Regulatory Information for crisaborole

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anacor Pharms Inc	EUCRISA	crisaborole	OINTMENT;TOPICAL	207695-001	Dec 14, 2016		RX	Yes	Yes
Anacor Pharms Inc	EUCRISA	crisaborole	OINTMENT;TOPICAL	207695-001	Dec 14, 2016		RX	Yes	Yes
Anacor Pharms Inc	EUCRISA	crisaborole	OINTMENT;TOPICAL	207695-001	Dec 14, 2016		RX	Yes	Yes			Y	Y
Anacor Pharms Inc	EUCRISA	crisaborole	OINTMENT;TOPICAL	207695-001	Dec 14, 2016		RX	Yes	Yes

Non-Orange Book US Patents for crisaborole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,582,621	Boron-containing small molecules
7,767,657	Boron-containing small molecules
9,029,353	Boron-containing small molecules as anti-inflammatory agents
9,566,289	Boron-containing small molecules

International Patents for crisaborole

Country	Document Number	Estimated Expiration
Hong Kong	1228917
Russian Federation	2008137086
Mexico	335993
Israel	185080